Lisa Olson
2023
In 2023, Lisa Olson earned a total compensation of $1.1M as Former Chief Scientific Officer at Dianthus Therapeutics, a 15% increase compared to previous year.
Compensation breakdown
| Bonus | $277,027 |
|---|---|
| Option Awards | $91,863 |
| Salary | $160,730 |
| Other | $598,393 |
| Total | $1,128,013 |
Olson received $598.4K in other compensation, accounting for 53% of the total pay in 2023.
Olson also received $277K in bonus, $91.9K in option awards and $160.7K in salary.
Rankings
In 2023, Lisa Olson's compensation ranked 1,077th out of 2,978 executives tracked by ExecPay. In other words, Olson earned more than 63.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,077 out of 2,978 | 64th |
Division Manufacturing | 639 out of 1,637 | 61st |
Major group Chemicals And Allied Products | 435 out of 906 | 52nd |
Industry group Drugs | 424 out of 869 | 51st |
Industry Pharmaceutical Preparations | 289 out of 627 | 54th |
Source: SEC filing on April 11, 2024.
Olson's colleagues
We found six more compensation records of executives who worked with Lisa Olson at Dianthus Therapeutics in 2023.
2023
Stephen Mahoney
Dianthus Therapeutics
Former President, Chief Financial and Operating Officer
2023
Thomas Beetham
Dianthus Therapeutics
Chief Legal Officer
2023
Jason Gardner
Dianthus Therapeutics
Chief Executive Officer
2023
Marino Garcia
Dianthus Therapeutics
Chief Executive Officer
2023
Simrat Randhawa
Dianthus Therapeutics
Chief Medical Officer
2023
Ryan Savitz
Dianthus Therapeutics